0B68 Sato, Takemi - Thomas Jefferson University - Thomas Jefferson University
txs123

Takemi Sato, MD

Contact Dr. Sato

111 South 11th Street
Suite 4240
Philadelphia, PA 19107

(215) 955-8874

Most Recent Peer-reviewed Publications

  1. Expression of insulin-like growth factor-1 receptor in metastatic uveal melanoma and implications for potential autocrine and paracrine tumor cell growth
  2. Tumor necrosis factor-α blockade and development of uveal melanoma: Expected adverse effect or just coincidence?
  3. Early arterial stasis during resin-based yttrium-90 radioembolization: Incidence and preliminary outcomes
  4. The potential role of sunitinib targeting melanomas
  5. Somatostatin receptor scintigraphy in patients with metastatic uveal melanoma
  6. A pilot study of sunitinib malate in patients with metastatic uveal melanoma
  7. Uveal melanoma trapped in the temple of doom
  8. Interleukin 6 mediates production of interleukin 10 in metastatic melanoma
  9. Lymph node ratio is an important and independent prognostic factor for patients with stage III melanoma
  10. Interleukin 10 in the tumor microenvironment: A target for anticancer immunotherapy
  11. Toxicities after radioembolization with yttrium-90 SIR-spheres: Incidence and contributing risk factors at a single center
  12. Moxifloxacin prophylaxis for chemoembolization or embolization in patients with previous biliary interventions: A pilot study
  13. Side-branch embolization before 90Y radioemb 05B4 olization: Rate of recanalization and new collateral development
  14. Tumor-derived interleukin-10 as a prognostic factor in stage III patients undergoing adjuvant treatment with an autologous melanoma cell vaccine
  15. Summary and assessment
  16. A phase 1-2 study of imexon plus dacarbazine in patients with unresectable metastatic melanoma
  17. Surgically unresectable regional melanoma metastases in a patient with renal failure and peripheral vascular disease: Are there safe and potentially effective treatments?
  18. Locoregional Management of Hepatic Metastasis From Primary Uveal Melanoma
  19. Human interleukin 10 receptor 1/IgG1-Fc fusion proteins: Immunoadhesins for human IL-10 with therapeutic potential
  20. High-dose immunoembolization: Survival benefit in patients with hepatic metastases from uveal melanoma
0